Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
How Bond Traders Reacted to Latest Inflation Data and Prep for Nvidia Earnings
Ed Egilinsky, managing director and head of sales and distribution & alternatives with Direxion, joined Cheddar News to discuss how bond traders are reacting to the latest consumer price index data and how they're positioning portfolios ahead of next week's release of Nvidia's earnings. Egilinsky also discussed some of the other bigger-cap companies, including Alphabet, Amazon and Apple.
Load More